3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Burkitt Lymphoma
28
Leukemia, Biphenotypic, Acute
15
Leukemia, Myeloid, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia
10
Myelodysplastic Syndromes
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
7
Osteosarcoma
6
Leukemia, Myeloid, Accelerated Phase
6
Blast Crisis
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Graft vs Host Disease
5
Medulloblastoma
4
Down Syndrome
4
Urinary Bladder Neoplasms
3
Recurrence
3
Primary Myelofibrosis
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Juvenile
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Thrombocythemia, Essential
2
Rhabdoid Tumor
2
Polycythemia Vera
2
Interventions
Carboplatin
5
pembrolizumab
3
Paclitaxel
3
Observation
3
Capecitabine
3
Azacitidine
3
venetoclax
2
pertuzumab
2
olaparib
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Oxaliplatin
2
Irinotecan
2
Immunotherapy
2
Chemoradiotherapy
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
taxane
1
talazoparib
1
tagraxofusp
1
sarilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Methotrexate
×
1 year
×
Clear all
No trials found.